nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritodrine—GALR3—cerebellum—hypothyroidism	0.0937	0.196	CbGeAlD
Ritodrine—GALR3—Peptide GPCRs—TSHR—hypothyroidism	0.0489	0.0937	CbGpPWpGaD
Ritodrine—PGD—adrenal cortex—hypothyroidism	0.0425	0.0889	CbGeAlD
Ritodrine—PGD—heart—hypothyroidism	0.0411	0.086	CbGeAlD
Ritodrine—PGD—NRF2 pathway—SLC5A7—hypothyroidism	0.0408	0.0781	CbGpPWpGaD
Ritodrine—PGD—cardiovascular system—hypothyroidism	0.0388	0.0811	CbGeAlD
Ritodrine—PGD—gonad—hypothyroidism	0.0352	0.0736	CbGeAlD
Ritodrine—PGD—pituitary gland—hypothyroidism	0.0343	0.0718	CbGeAlD
Ritodrine—PGD—adrenal gland—hypothyroidism	0.0307	0.0642	CbGeAlD
Ritodrine—PGD—blood—hypothyroidism	0.0307	0.0642	CbGeAlD
Ritodrine—PGD—thyroid gland—hypothyroidism	0.0296	0.0619	CbGeAlD
Ritodrine—PGD—female gonad—hypothyroidism	0.0286	0.0598	CbGeAlD
Ritodrine—GALR3—Peptide ligand-binding receptors—TRH—hypothyroidism	0.0258	0.0495	CbGpPWpGaD
Ritodrine—PGD—testis—hypothyroidism	0.0254	0.0531	CbGeAlD
Ritodrine—PGD—liver—hypothyroidism	0.024	0.0502	CbGeAlD
Ritodrine—PGD—cerebellum—hypothyroidism	0.0234	0.049	CbGeAlD
Ritodrine—ADRB2—Arf6 trafficking events—CLTC—hypothyroidism	0.0208	0.0398	CbGpPWpGaD
Ritodrine—ADRB2—Arf6 signaling events—TSHR—hypothyroidism	0.0203	0.0388	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.0173	0.0332	CbGpPWpGaD
Ritodrine—PGD—NRF2 pathway—SLC5A5—hypothyroidism	0.0163	0.0312	CbGpPWpGaD
Ritodrine—ADRB2—Arf6 trafficking events—TSHR—hypothyroidism	0.016	0.0307	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.0154	0.0296	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.0154	0.0296	CbGpPWpGaD
Ritodrine—GALR3—Peptide ligand-binding receptors—AVP—hypothyroidism	0.0136	0.026	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—TRH—hypothyroidism	0.0132	0.0253	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—TSHB—hypothyroidism	0.0118	0.0225	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—TSHR—hypothyroidism	0.0118	0.0225	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.0091	0.0174	CbGpPWpGaD
Ritodrine—GALR3—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00901	0.0173	CbGpPWpGaD
Ritodrine—PGD—Metabolism—IYD—hypothyroidism	0.00882	0.0169	CbGpPWpGaD
Ritodrine—GALR3—G alpha (i) signalling events—POMC—hypothyroidism	0.0076	0.0146	CbGpPWpGaD
Ritodrine—PGD—Metabolism—ATP5O—hypothyroidism	0.0075	0.0144	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—TRH—hypothyroidism	0.00745	0.0143	CbGpPWpGaD
Ritodrine—ADRB2—G alpha (s) signalling events—TSHB—hypothyroidism	0.00737	0.0141	CbGpPWpGaD
Ritodrine—ADRB2—G alpha (s) signalling events—TSHR—hypothyroidism	0.00737	0.0141	CbGpPWpGaD
Ritodrine—PGD—Metabolism—TPO—hypothyroidism	0.00705	0.0135	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—AVP—hypothyroidism	0.00693	0.0133	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—TRH—hypothyroidism	0.00677	0.013	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—TSHB—hypothyroidism	0.00664	0.0127	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—TSHR—hypothyroidism	0.00664	0.0127	CbGpPWpGaD
Ritodrine—GALR3—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00604	0.0116	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—TSHB—hypothyroidism	0.00603	0.0116	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—TSHR—hypothyroidism	0.00603	0.0116	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—CLTC—hypothyroidism	0.00462	0.00886	CbGpPWpGaD
Ritodrine—GALR3—GPCR ligand binding—POMC—hypothyroidism	0.0046	0.00882	CbGpPWpGaD
Ritodrine—ADRB2—G alpha (s) signalling events—AVP—hypothyroidism	0.00434	0.00832	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—VAV3—hypothyroidism	0.00406	0.00778	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TRH—hypothyroidism	0.004	0.00766	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00394	0.00755	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—AVP—hypothyroidism	0.00391	0.0075	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—VAV3—hypothyroidism	0.00369	0.00707	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TSHB—hypothyroidism	0.00356	0.00683	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—TSHR—hypothyroidism	0.00356	0.00683	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—AVP—hypothyroidism	0.00355	0.00681	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00351	0.00673	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00351	0.00673	CbGpPWpGaD
Ritodrine—PGD—Metabolism—TSHB—hypothyroidism	0.00327	0.00626	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—SH2B3—hypothyroidism	0.00318	0.00608	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—TRH—hypothyroidism	0.003	0.00575	CbGpPWpGaD
Ritodrine—PGD—Metabolism—PIK3C2A—hypothyroidism	0.00291	0.00558	CbGpPWpGaD
Ritodrine—ADRB2—G alpha (s) signalling events—POMC—hypothyroidism	0.00289	0.00553	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—TSHB—hypothyroidism	0.00268	0.00513	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—TSHR—hypothyroidism	0.00268	0.00513	CbGpPWpGaD
Ritodrine—GALR3—GPCR downstream signaling—POMC—hypothyroidism	0.0026	0.00498	CbGpPWpGaD
Ritodrine—PGD—Disease—PRL—hypothyroidism	0.00258	0.00494	CbGpPWpGaD
Ritodrine—PGD—Metabolism—SLC5A5—hypothyroidism	0.00244	0.00468	CbGpPWpGaD
Ritodrine—GALR3—Signaling by GPCR—POMC—hypothyroidism	0.00236	0.00453	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—PRL—hypothyroidism	0.00236	0.00451	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—VAV3—hypothyroidism	0.00218	0.00418	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—AVP—hypothyroidism	0.0021	0.00402	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00207	0.00397	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—TRH—hypothyroidism	0.0017	0.00325	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—AVP—hypothyroidism	0.00158	0.00302	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—TRH—hypothyroidism	0.00154	0.00295	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—TSHB—hypothyroidism	0.00151	0.0029	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—TSHR—hypothyroidism	0.00151	0.0029	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—POMC—hypothyroidism	0.0014	0.00267	CbGpPWpGaD
Ritodrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00138	0.00264	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—TSHB—hypothyroidism	0.00137	0.00263	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—TSHR—hypothyroidism	0.00137	0.00263	CbGpPWpGaD
Ritodrine—GALR3—Signaling Pathways—IGF1—hypothyroidism	0.00134	0.00257	CbGpPWpGaD
Ritodrine—PGD—Metabolism—POMC—hypothyroidism	0.00128	0.00245	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—CLTC—hypothyroidism	0.00105	0.00202	CbGpPWpGaD
Ritodrine—ADRB2—GPCR ligand binding—POMC—hypothyroidism	0.00105	0.00201	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—VAV3—hypothyroidism	0.000925	0.00177	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TRH—hypothyroidism	0.00091	0.00174	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—AVP—hypothyroidism	0.000891	0.00171	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—VAV3—hypothyroidism	0.00084	0.00161	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TSHR—hypothyroidism	0.000811	0.00155	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—TSHB—hypothyroidism	0.000811	0.00155	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—AVP—hypothyroidism	0.000809	0.00155	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—SH2B3—hypothyroidism	0.000723	0.00139	CbGpPWpGaD
Ritodrine—ADRB2—GPCR downstream signaling—POMC—hypothyroidism	0.000592	0.00113	CbGpPWpGaD
Ritodrine—ADRB2—Signaling by GPCR—POMC—hypothyroidism	0.000538	0.00103	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—PRL—hypothyroidism	0.000536	0.00103	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—VAV3—hypothyroidism	0.000496	0.000951	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—AVP—hypothyroidism	0.000478	0.000916	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—POMC—hypothyroidism	0.000318	0.000609	CbGpPWpGaD
Ritodrine—ADRB2—Signaling Pathways—IGF1—hypothyroidism	0.000306	0.000585	CbGpPWpGaD
